Plexāā recently announced a new partnership with Panasonic Manufacturing UK as their contract manufacturer for the Bloom device. The Bloom platform helps patients prepare for breast cancer surgery and reconstruction by using supraphysiological preconditioning. This technique intermittently heats the skin causing the release of heat-shock proteins that cause vasodilation and increased blood flow to the area. According to Plexāā, this technique has been shown to reduce wound healing complications in proof-of-concept clinical trials.
Bloom is being trialed at Stanford University Hospital in California and plans for a market launch in the U.S. in spring 2025.
Related: Fractyl Health to focus on Revita and Rejuva Programs
The collaboration is expected to accelerate the production and scaling of the company’s technology.
“Partnering with Panasonic Manufacturing UK marks a crucial milestone for us. Their renowned expertise in manufacturing excellence and commitment to green manufacturing will enable us to efficiently bring the device to market and scale up globally in-line with demand,” Plexāā founder Saahil Mehta said in a news release.
